UnitedHealth Group Incorporated $UNH Shares Sold by Pacific Capital Partners Ltd

Key Points

• Pacific Capital Partners Ltd significantly reduced its stake in UnitedHealth Group by 65.5%, lowering its holdings to 4,750 shares valued at approximately $1.48 million.
• Several large investors, including Bayforest Capital Ltd and Clal Insurance Enterprises Holdings Ltd, have increased their positions in UnitedHealth Group during the first quarter, indicating varying confidence levels among institutional investors.
• Wall Street analysts show a mixed sentiment on UnitedHealth Group, with a consensus rating of "Moderate Buy" and a price target range suggesting potential for growth ahead.

Pacific Capital Partners Ltd cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 65.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,750 shares of the healthcare conglomerate's stock after selling 9,000 shares during the period. UnitedHealth Group comprises 1.4% of Pacific Capital Partners Ltd's portfolio, making the stock its 26th biggest position. Pacific Capital Partners Ltd's holdings in UnitedHealth Group were worth $1,482,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in UNH. GAMMA Investing LLC grew its stake in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Nuveen LLC purchased a new position in UnitedHealth Group during the 1st quarter worth $3,846,764,000. Vanguard Group Inc. grew its stake in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its stake in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. TD Securities reiterated a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Truist Financial boosted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research note on Tuesday, September 9th. Robert W. Baird reiterated an "underperform" rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Barclays upped their target price on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research note on Thursday, September 4th. Finally, Morgan Stanley upped their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research note on Friday. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Price Performance

UNH stock traded down $8.21 during mid-day trading on Tuesday, reaching $339.68. 10,204,644 shares of the company's stock were exchanged, compared to its average volume of 13,047,916. The company has a market cap of $307.64 billion, a price-to-earnings ratio of 14.72, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. The stock's 50 day moving average is $292.87 and its 200 day moving average is $367.43. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.